Cargando…

Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations

Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation and episodes of worsening respiratory symptoms and pulmonary function, termed acute exacerbations of COPD (AECOPD). AECOPD episodes are associated with heightened airway inflammation and are often triggered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unninayar, Dana, Abdallah, Sara J, Cameron, D William, Cowan, Juthaporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936713/ https://www.ncbi.nlm.nih.gov/pubmed/33688179 http://dx.doi.org/10.2147/COPD.S283832

Ejemplares similares

Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis
por: Unninayar, Dana, et al.
Publicado: (2023)

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
por: Cowan, Juthaporn, et al.
Publicado: (2021)

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Cowan, Juthaporn, et al.
Publicado: (2015)

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations
por: Cowan, Juthaporn, et al.
Publicado: (2018)

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry
por: Abadeh, Armin, et al.
Publicado: (2023)

Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance
por: Pedraza-Sánchez, Sigifredo, et al.
Publicado: (2023)

Polyvalent Immunoglobulin Preparations Inhibit Pneumolysin-Induced Platelet Destruction
por: Wiebe, Friederike, et al.
Publicado: (2022)

Cutaquig(®) Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products
por: Brownlee, Sydney, et al.
Publicado: (2022)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency
por: Dinh, Tri, et al.
Publicado: (2019)

Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation
por: Cowan, Juthaporn, et al.
Publicado: (2015)

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
por: Dumitru, Adrian Vasile, et al.
Publicado: (2023)

Clinical outcomes of immunoglobulin use in solid organ transplant recipients: protocol for a systematic review and meta-analysis
por: Cowan, Juthaporn, et al.
Publicado: (2015)

The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
por: Young, Megan K.
Publicado: (2019)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

The Value of Polyvalent Serum
por: Dunlop, C. W.
Publicado: (1912)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Treatment of Pneumonia by a Polyvalent Stock Pneumococcic Vaccine
por: Charteris, Frank
Publicado: (1912)

Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies
por: Grünewald, Benedikt, et al.
Publicado: (2016)

Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections—Interactions with Neutrophils, Complement, and Coagulation Pathways
por: Schmidt, Carolin, et al.
Publicado: (2023)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Airways inflammation and treatment during acute exacerbations of COPD
por: Bathoorn, Erik, et al.
Publicado: (2008)

The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System
por: Schmidt, Carolin, et al.
Publicado: (2021)

Polyvalent vaccines: High-maintenance heroes
por: Schlingmann, Barbara, et al.
Publicado: (2018)

Polyvalent guide RNAs for CRISPR antivirals
por: Bagchi, Rammyani, et al.
Publicado: (2022)

Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections
por: Braido, F, et al.
Publicado: (2007)

Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
por: Brennan, Michelle, et al.
Publicado: (2022)

COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review
por: Poenaru, Sonia, et al.
Publicado: (2021)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation
por: Aydin, Cihan, et al.
Publicado: (2021)

Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Acute COPD exacerbation treatment with noninvasive ventilation
por: Ralf, Ewert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pl77m2am8tjebj9nleqtfghplt